Search form
Search
contact us
Navigation
home
boards
job center
job ratings
cp wire
device news
trending now
trending in pharma/biotech
trending in device
pharmagather
advertise
Legal Help
login/register
You are here
Home
»
companies
» Vir Biotechnology
Vir Biotechnology
With $500M-plus, a buyout and two new billion-dollar pacts, upstart Vir is ready to roll on infectious diseases
With $500M-plus, a buyout and two new billion-dollar pacts, upstart Vir is ready to roll on infectious diseases
Endpoints
Vir Biotechnology
George Scangos
Alnylam
Visterra
Flag link:
Ex-Biogen chief George Scangos to spearhead a Gates-backed startup with big plans to fight infectious diseases
Ex-Biogen chief George Scangos to spearhead a Gates-backed startup with big plans to fight infectious diseases
Endpoints
Biogen
George Scangos
Bill Gates
Vir Biotechnology
Flag link:
